72 related articles for article (PubMed ID: 8240592)
1. Pregnancy outcome following fetal exposure to tiaprofenic acid in the first trimester.
Pastuszak A; Pinelli M; Koren G
Am J Perinatol; 1993 Sep; 10(5):354-7. PubMed ID: 8240592
[TBL] [Abstract][Full Text] [Related]
2. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
[TBL] [Abstract][Full Text] [Related]
3. First-trimester exposure to alprazolam.
St Clair SM; Schirmer RG
Obstet Gynecol; 1992 Nov; 80(5):843-6. PubMed ID: 1407925
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome following first trimester exposure to cocaine in social users in Toronto, Canada.
Graham K; Dimitrakoudis D; Pellegrini E; Koren G
Vet Hum Toxicol; 1989 Apr; 31(2):143-8. PubMed ID: 2929123
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome and infant development following gestational cocaine use by social cocaine users in Toronto, Canada.
Graham K; Feigenbaum A; Pastuszak A; Nulman I; Weksberg R; Einarson T; Goldberg S; Ashby S; Koren G
Clin Invest Med; 1992 Aug; 15(4):384-94. PubMed ID: 1516296
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome following exposure to permethrin and use of teratogen information.
Kennedy D; Hurst V; Konradsdottir E; Einarson A
Am J Perinatol; 2005 Feb; 22(2):87-90. PubMed ID: 15731987
[TBL] [Abstract][Full Text] [Related]
7. Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study.
Bar-Oz B; Clementi M; Di Giantonio E; Greenberg R; Beer M; Merlob P; Arnon J; Ornoy A; Zimmerman DM; Berkovitch M
Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):176-9. PubMed ID: 15808375
[TBL] [Abstract][Full Text] [Related]
8. Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.
Daniel S; Matok I; Gorodischer R; Koren G; Uziel E; Wiznitzer A; Levy A
J Rheumatol; 2012 Nov; 39(11):2163-9. PubMed ID: 22984274
[TBL] [Abstract][Full Text] [Related]
9. Fetal outcome after in utero exposure to cancer chemotherapy.
Zemlickis D; Lishner M; Degendorfer P; Panzarella T; Sutcliffe SB; Koren G
Arch Intern Med; 1992 Mar; 152(3):573-6. PubMed ID: 1546920
[TBL] [Abstract][Full Text] [Related]
10. Fetal outcome following roxithromycin exposure in early pregnancy.
Chun JY; Han JY; Ahn HK; Choi JS; Koong MK; Nava-Ocampo AA; Koren G
J Matern Fetal Neonatal Med; 2006 Mar; 19(3):189-92. PubMed ID: 16690513
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome post renal transplantation.
Sgro MD; Barozzino T; Mirghani HM; Sermer M; Moscato L; Akoury H; Koren G; Chitayat DA
Teratology; 2002 Jan; 65(1):5-9. PubMed ID: 11835226
[TBL] [Abstract][Full Text] [Related]
12. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin.
McLintock C; McCowan LM; North RA
BJOG; 2009 Nov; 116(12):1585-92. PubMed ID: 19681850
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
Diav-Citrin O; Okotore B; Lucarelli K; Koren G
Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
[TBL] [Abstract][Full Text] [Related]
14. Safety of nonsteroidal antiinflammatory drugs in pregnant patients with rheumatic disease.
Ostensen M; Ostensen H
J Rheumatol; 1996 Jun; 23(6):1045-9. PubMed ID: 8782138
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome after in utero exposure to colchicine.
Diav-Citrin O; Shechtman S; Schwartz V; Avgil-Tsadok M; Finkel-Pekarsky V; Wajnberg R; Arnon J; Berkovitch M; Ornoy A
Am J Obstet Gynecol; 2010 Aug; 203(2):144.e1-6. PubMed ID: 20579964
[TBL] [Abstract][Full Text] [Related]
16. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC
Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284
[TBL] [Abstract][Full Text] [Related]
17. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort.
Boskovic R; Wide R; Wolpin J; Bauer DJ; Koren G
Neurology; 2005 Sep; 65(6):807-11. PubMed ID: 16186517
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
19. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study.
Berkovitch M; Diav-Citrin O; Greenberg R; Cohen M; Bulkowstein M; Shechtman S; Bortnik O; Arnon J; Ornoy A
Br J Clin Pharmacol; 2004 Sep; 58(3):298-302. PubMed ID: 15327589
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]